Current investigations into the drug are yielding significant outcomes regarding body composition . Initially intended for treating type 2 diabetes , this GLP-1 receptor agonist has shown substantial https://privatebookmark.com/story21466184/semaglutide-research-exploring-potential-weight-loss-possibilities